Humanigen Inc (HGEN)

Track

Stock chart
Ticker: HGEN Exchange: OTC


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Earnings
Earnings
 
Value bought

Past 90 days

 
Value sold

Past 90 days

 
Net insiders buying

Past 90 days

 
Trades (buy and sell)

Past 90 days

Abbreviations B: Buy, S: Sell, PP: Planned purchase, PS: Planned sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2023-10-20 2023-10-18 S Sale

Chappell Dale

Chief Scientific Officer

Executive Director Large shareholder
276,210 -3.2%
0.01
USD 3,038 		276,210 -3.2% 0.01 USD 3,038
2023-10-20 2023-10-18 S Sale

Chappell Dale

Chief Scientific Officer

Executive Director Large shareholder
75,887 -3.2%
0.01
USD 835 		75,887 -3.2% 0.01 USD 835
2023-10-20 2023-10-18 S Sale

Chappell Dale

Chief Scientific Officer

Executive Director Large shareholder
34,253 -3.2%
0.01
USD 377 		34,253 -3.2% 0.01 USD 377
2022-05-20 2022-05-20 B Purchase

Chappell Dale

Chief Scientific Officer

Executive Director Large shareholder
381,841 +4.6%
2.23
USD 850,742 		381,841 +4.6% 2.23 USD 850,742
2022-05-20 2022-05-20 B Purchase

Chappell Dale

Chief Scientific Officer

Executive Director Large shareholder
109,098 +4.8%
2.23
USD 243,070 		109,098 +4.8% 2.23 USD 243,070
2022-05-20 2022-05-20 B Purchase

Chappell Dale

Chief Scientific Officer

Executive Director Large shareholder
54,549 +5.3%
2.23
USD 121,535 		54,549 +5.3% 2.23 USD 121,535
2022-05-20 2022-05-19 B Purchase

Chappell Dale

Chief Scientific Officer

Executive Director Large shareholder
226,665 +2.8%
2.19
USD 495,490 		226,665 +2.8% 2.19 USD 495,490
2022-05-20 2022-05-19 B Purchase

Chappell Dale

Chief Scientific Officer

Executive Director Large shareholder
64,762 +2.9%
2.19
USD 141,570 		64,762 +2.9% 2.19 USD 141,570
2022-05-20 2022-05-19 B Purchase

Chappell Dale

Chief Scientific Officer

Executive Director Large shareholder
32,381 +3.3%
2.19
USD 70,785 		32,381 +3.3% 2.19 USD 70,785
2022-05-20 2022-05-18 B Purchase

Chappell Dale

Chief Scientific Officer

Executive Director Large shareholder
121,590 +1.5%
1.96
USD 238,560 		121,590 +1.5% 1.96 USD 238,560
2022-05-20 2022-05-18 B Purchase

Chappell Dale

Chief Scientific Officer

Executive Director Large shareholder
34,740 +1.6%
1.96
USD 68,160 		34,740 +1.6% 1.96 USD 68,160
2022-05-20 2022-05-18 B Purchase

Chappell Dale

Chief Scientific Officer

Executive Director Large shareholder
17,370 +1.8%
1.96
USD 34,080 		17,370 +1.8% 1.96 USD 34,080
2022-03-15 2022-03-11 B Purchase

Chappell Dale

Chief Scientific Officer

Executive Director Large shareholder
700,000 +9.7%
3.00
USD 2,100,000 		700,000 +9.7% 3.00 USD 2,100,000
2022-03-15 2022-03-11 B Purchase

Chappell Dale

Chief Scientific Officer

Executive Director Large shareholder
200,000 +10.1%
3.00
USD 600,000 		200,000 +10.1% 3.00 USD 600,000
2022-03-15 2022-03-11 B Purchase

Chappell Dale

Chief Scientific Officer

Executive Director Large shareholder
100,000 +11.5%
3.00
USD 300,000 		100,000 +11.5% 3.00 USD 300,000
2022-03-14 2022-03-09 B Purchase

Kilcoyne Adrian

Chief Medical Officer

Officer
5,000 +71.4%
2.78
USD 13,900 		5,000 +71.4% 2.78 USD 13,900
2022-03-14 2022-03-08 B Purchase

Kilcoyne Adrian

Chief Medical Officer

Officer
7,000 +inf%
2.53
USD 17,710 		7,000 +inf% 2.53 USD 17,710
2022-03-04 2022-03-02 B Purchase

Durrant Cameron

Chief Executive Officer

Executive Director
40,000 +133.3%
2.34
USD 93,600 		40,000 +133.3% 2.34 USD 93,600
2022-03-04 2022-03-02 B Purchase

Jordan Edward P.

Chief Commercial Officer

Officer
12,500 +inf%
2.32
USD 29,000 		12,500 +inf% 2.32 USD 29,000
2021-06-25 2021-06-25 PS Planned sale

Chappell Dale

Chief Scientific Officer

Executive Director Large shareholder
725,000 -8.1%
17.80
USD 12,907,538 		725,000 -8.1% 17.80 USD 12,907,538
// ... existing code ...